| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
DOK1 |
DOK1: Docking protein 1 |
13.490 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
13.490 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
RASA3 |
RASA3: Ras GTPase-activating protein 3 |
13.490 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
NEDD9 |
NEDD9, CASL: Enhancer of filamentation 1 |
13.490 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
ELMO1 |
IPI00219532 |
13.490 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
KIAA1804 |
MLK4, KIAA1804: Mitogen-activated protein kinase kinase kinase |
13.490 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
13.490 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
13.490 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
STAT3 |
|
13.490 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
ELMO1 |
IPI00219532 |
13.490 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
NEDD9 |
NEDD9, CASL: Enhancer of filamentation 1 |
13.490 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
CDC2L5 |
CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 |
13.490 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
13.490 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
ITSN2 |
ITSN2, KIAA1256, SH3D1B, SWAP: Intersectin-2 |
13.490 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
13.490 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
13.490 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
13.490 |
Evidence |
|
| LCP1 |
LCP1, PLS2: Plastin-2 |
STAT3 |
|
13.490 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
13.490 |
Evidence |
|
| HAPLN1 |
HAPLN1, CRTL1: Hyaluronan and proteoglycan link protein 1 precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
13.490 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
13.490 |
Evidence |
|
| HCK |
IPI00029769 |
CNN2 |
CNN2: Calponin-2 |
13.490 |
Evidence |
|
| HCK |
IPI00029769 |
ELMO1 |
IPI00219532 |
13.490 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
13.490 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
13.490 |
Evidence |
|